ELAN
Price
$11.02
Change
-$0.11 (-0.99%)
Updated
Feb 21 closing price
Capitalization
7.87B
2 days until earnings call
TAK
Price
$14.06
Change
+$0.20 (+1.44%)
Updated
Feb 21 closing price
Capitalization
43.11B
74 days until earnings call
Ad is loading...

ELAN vs TAK

Header iconELAN vs TAK Comparison
Open Charts ELAN vs TAKBanner chart's image
Elanco Animal Health
Price$11.02
Change-$0.11 (-0.99%)
Volume$7.33M
Capitalization7.87B
Takeda Pharmaceutical
Price$14.06
Change+$0.20 (+1.44%)
Volume$1.47M
Capitalization43.11B
ELAN vs TAK Comparison Chart
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. TAK commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and TAK is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ELAN: $11.32 vs. TAK: $13.90)
Brand notoriety: ELAN: Notable vs. TAK: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELAN: 77% vs. TAK: 92%
Market capitalization -- ELAN: $7.87B vs. TAK: $43.11B
ELAN [@Pharmaceuticals: Other] is valued at $7.87B. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whileTAK’s FA Score has 1 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • TAK’s FA Score: 1 green, 4 red.
According to our system of comparison, TAK is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 4 TA indicator(s) are bullish while TAK’s TA Score has 5 bullish TA indicator(s).

  • ELAN’s TA Score: 4 bullish, 4 bearish.
  • TAK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TAK is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Other) experienced а -0.79% price change this week, while TAK (@Pharmaceuticals: Other) price change was +3.42% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +77.53%, and the average quarterly price growth was +51.31%.

Reported Earning Dates

ELAN is expected to report earnings on May 13, 2025.

TAK is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($43.1B) has a higher market cap than ELAN($7.87B). TAK YTD gains are higher at: 4.985 vs. ELAN (-6.524). TAK has higher annual earnings (EBITDA): 1.01T vs. ELAN (-224M). TAK has more cash in the bank: 317B vs. ELAN (352M). ELAN has less debt than TAK: ELAN (5.77B) vs TAK (4.66T). TAK has higher revenues than ELAN: TAK (4.17T) vs ELAN (4.42B).
ELANTAKELAN / TAK
Capitalization7.87B43.1B18%
EBITDA-224M1.01T-0%
Gain YTD-6.5244.985-131%
P/E RatioN/A36.79-
Revenue4.42B4.17T0%
Total Cash352M317B0%
Total Debt5.77B4.66T0%
FUNDAMENTALS RATINGS
ELAN vs TAK: Fundamental Ratings
ELAN
TAK
OUTLOOK RATING
1..100
6372
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
10
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8685
PRICE GROWTH RATING
1..100
8252
P/E GROWTH RATING
1..100
8076
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (10) in the Pharmaceuticals Major industry is somewhat better than the same rating for ELAN (58) in the Agricultural Commodities Or Milling industry. This means that TAK’s stock grew somewhat faster than ELAN’s over the last 12 months.

TAK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that TAK’s stock grew similarly to ELAN’s over the last 12 months.

TAK's SMR Rating (85) in the Pharmaceuticals Major industry is in the same range as ELAN (86) in the Agricultural Commodities Or Milling industry. This means that TAK’s stock grew similarly to ELAN’s over the last 12 months.

TAK's Price Growth Rating (52) in the Pharmaceuticals Major industry is in the same range as ELAN (82) in the Agricultural Commodities Or Milling industry. This means that TAK’s stock grew similarly to ELAN’s over the last 12 months.

TAK's P/E Growth Rating (76) in the Pharmaceuticals Major industry is in the same range as ELAN (80) in the Agricultural Commodities Or Milling industry. This means that TAK’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANTAK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
66%
Bearish Trend 6 days ago
48%
Momentum
ODDS (%)
Bearish Trend 6 days ago
77%
Bullish Trend 6 days ago
37%
MACD
ODDS (%)
Bearish Trend 6 days ago
64%
Bullish Trend 6 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
75%
Bullish Trend 6 days ago
44%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
73%
Bullish Trend 6 days ago
41%
Advances
ODDS (%)
Bullish Trend 25 days ago
64%
Bullish Trend 18 days ago
45%
Declines
ODDS (%)
Bearish Trend 13 days ago
75%
Bearish Trend 21 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
68%
Bearish Trend 6 days ago
45%
Aroon
ODDS (%)
Bullish Trend 6 days ago
73%
Bearish Trend 6 days ago
42%
View a ticker or compare two or three
Ad is loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ELAN and

Correlation & Price change

A.I.dvisor tells us that ELAN and PCRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAN and PCRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+0.62%
PCRX - ELAN
32%
Poorly correlated
+3.93%
PAHC - ELAN
28%
Poorly correlated
+0.19%
TAK - ELAN
27%
Poorly correlated
+2.66%
PHCUF - ELAN
24%
Poorly correlated
N/A
ZTS - ELAN
24%
Poorly correlated
-0.66%
More

TAK and

Correlation & Price change

A.I.dvisor tells us that TAK and ELAN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TAK and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
+2.66%
ELAN - TAK
27%
Poorly correlated
+0.62%
HLN - TAK
26%
Poorly correlated
+2.88%
RDY - TAK
25%
Poorly correlated
-0.29%
ZTS - TAK
24%
Poorly correlated
-0.66%
SNOA - TAK
24%
Poorly correlated
+0.50%
More